All stock reports

RADIOCITY evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-28T23:40:31.876280+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1744325000.0
net_income
-533241000.0
operating_cash_flow
418317000.0
free_cash_flow
368469000.0
total_assets
4959195000.0
total_liabilities
505764000.0
total_equity
4453431000.0
cash
44146000.0
total_debt
236384000.0
revenue_growth
-0.25609142911731475
earnings_growth
0.5759109850164021
net_margin
-0.30570048586129306
roe
-0.11973711953772272
debt_to_equity
0.0530790754364444
cash_conversion
-0.7844801881325705
free_cash_flow_margin
0.2112387313144053
trailing_pe
121.53
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-268d8d72eb6f6d488382dbae557dc4f3068c122cc8c78818c4f05d95398bd5bd
Policy
stock-decisions-v1
Evidence bundle hash
eb376e84a5742cb981212c74c95733073569edaf8ea274b9010f29750958dd90
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: e91644248a18bcc53e22981ec941aa78d88da3d94f05681f057b943b3e0921ae
  • daily-price: ad5b594ec65e083feb0f86b6bffce5cf7887f81901ca157788aa3e990393d7dc
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits